Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “alzheimer”

52 pharma patents match "alzheimer" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 52
Index total 30,257
Page 3 / 3

Quick answer

This filtered view shows 52 pharmaceutical patents matching "alzheimer" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

52 results for “alzheimer” · 30,257 patents in full index Clear search

  1. US 7846892

    Compositions and methods for Alzheimer's disease

    Primex Clinical Laboratories, Inc. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted

  2. US 7479579

    Triple transgenic mouse model of Alzheimer's disease

    The Regents of the University of California · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  3. US 6673332

    Assays for inhibitors of neuronal transport of Alzheimer's amyloid precursor protein

    The Regents of the University of California · Granted Jan 6, 2004 · Expires Jan 1, 2024

    expired

  4. US 6410747

    Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 25, 2002 · Expires Jun 20, 2022

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.